LVM Capital Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $762K | Sell |
9,745
-1,465
| -13% | -$118K | 0.06% | 90 |
|
|
2026
Q1 | $971K | Sell |
11,210
-986
| -8% | -$94.5K | 0.09% | 77 |
|
|
2025
Q4 | $1.17M | Sell |
12,196
-1,505
| -11% | -$146K | 0.11% | 71 |
|
|
2025
Q3 | $1.3M | Sell |
13,701
-1,200
| -8% | -$110K | 0.13% | 67 |
|
|
2025
Q2 | $1.3M | Sell |
14,901
-400
| -3% | -$33.9K | 0.13% | 67 |
|
|
2025
Q1 | $1.38M | Sell |
15,301
-2,802
| -15% | -$251K | 0.15% | 65 |
|
|
2024
Q4 | $1.45M | Sell |
18,103
-13,838
| -43% | -$1.2M | 0.16% | 63 |
|
|
2024
Q3 | $2.51M | Hold |
31,941
| – | – | 0.29% | 51 |
|
|
2024
Q2 | $2.51M | Sell |
31,941
-3,518
| -10% | -$288K | 0.29% | 51 |
|
|
2024
Q1 | $3.09M | Sell |
35,459
-5,420
| -13% | -$463K | 0.37% | 48 |
|
|
2023
Q4 | $3.37M | Sell |
40,879
-7,335
| -15% | -$559K | 0.43% | 46 |
|
|
2023
Q3 | $3.78M | Sell |
48,214
-24,260
| -33% | -$2.03M | 0.53% | 43 |
|
|
2023
Q2 | $6.38M | Sell |
72,474
-160
| -0.2% | -$13.8K | 0.85% | 35 |
|
|
2023
Q1 | $5.86M | Sell |
72,634
-1,201
| -2% | -$97.9K | 0.81% | 37 |
|
|
2022
Q4 | $5.74M | Sell |
73,835
-30,061
| -29% | -$2.44M | 0.83% | 38 |
|
|
2022
Q3 | $8.39M | Sell |
103,896
-3,505
| -3% | -$315K | 1.28% | 32 |
|
|
2022
Q2 | $9.64M | Buy |
107,401
+6,100
| +6% | +$618K | 1.4% | 28 |
|
|
2022
Q1 | $11.2M | Buy |
101,301
+5,190
| +5% | +$548K | 1.48% | 27 |
|
|
2021
Q4 | $9.94M | Buy |
96,111
+94,059
| +4,584% | +$10.9M | 1.33% | 28 |
|
|
2021
Q3 | $257K | Buy |
2,052
+40
| +2% | +$5.18K | 0.04% | 110 |
|
|
2021
Q2 | $250K | Hold |
2,012
| – | – | 0.04% | 113 |
|
|
2021
Q1 | $238K | Buy |
2,012
+100
| +5% | +$11.7K | 0.04% | 113 |
|
|
2020
Q4 | $224K | Buy |
+1,912
| New | +$210K | 0.04% | 111 |
|
|
2020
Q1 | – | Sell |
-1,827
| Closed | -$207K | – | 111 |
|
|
2019
Q4 | $207K | Buy |
+1,827
| New | +$200K | 0.04% | 110 |
|
|
2018
Q4 | – | Sell |
-2,087
| Closed | -$205K | – | 109 |
|
|
2018
Q3 | $205K | Buy |
+2,087
| New | +$193K | 0.05% | 110 |
|
|
2016
Q3 | – | Sell |
-2,497
| Closed | -$217K | – | 124 |
|
|
2016
Q2 | $217K | Buy |
+2,497
| New | +$202K | 0.06% | 105 |
|
|
2015
Q3 | – | Sell |
-4,081
| Closed | -$302K | – | 111 |
|
|
2015
Q2 | $302K | Hold |
4,081
| – | – | 0.1% | 88 |
|
|
2015
Q1 | $318K | Buy |
+4,081
| New | +$309K | 0.11% | 82 |
|
Other funds holding MDT
LVM Capital Management's MDT Position: Q2 2026 in Review
LVM Capital Management reduced its Medtronic (MDT) stake by 13% in Q2 2026, selling an estimated $118K and leaving 9,745 shares worth $762K. The position accounts for 0.06% of the portfolio, ranked #90.
LVM Capital Management first reported a position in MDT in Q1 2015 and has held it in 28 quarters since. The position peaked at $11.2M in Q1 2022. 2,140 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- LVM Capital Management held 9,745 shares of Medtronic worth $762K as of Q2 2026.
- LVM Capital Management sold 1,465 Medtronic shares in Q2 2026, an estimated $118K.
- Medtronic made up 0.06% of LVM Capital Management's portfolio in Q2 2026, its #90 holding.
- LVM Capital Management first reported a position in Medtronic in Q1 2015 and has held it in 28 quarters since.
- LVM Capital Management's Medtronic position peaked at $11.2M in Q1 2022.
- 2,140 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on LVM Capital Management's 13F filing for Q2 2026, filed 9 Jul 2026.